Here is the just released Frontiers of Neurology Review. In the manuscript, we gave an update of all the results of the ongoing immunotherapy trials of AD and CAA, with a particular focus on the treatment-related ARIA side effects and the most promising candidate biomarkers currently available.

DiFrancesco JC, Longoni M and Piazza F.

Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.

Front Neurol. 2015 Sep 25;6:207. doi: 10.3389/fneur.2015.00207. eCollection 2015. Review.

Manuscript link:


Do not forget to “Like” our iCAB International Network Facebook Page in order to receive updates on the CAA and AD Community and Research!!

For further information: